BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35069035)

  • 21. Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma.
    Surov A; Meyer HJ; Leifels L; Höhn AK; Richter C; Winter K
    Oncotarget; 2018 Apr; 9(30):21070-21077. PubMed ID: 29765520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
    Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
    Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67.
    Liu B; Gao H; Zhou F; Zhao W; Yang Y
    Clin Radiol; 2024 Jun; 79(6):e826-e833. PubMed ID: 38582634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
    Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
    Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation Between Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters in Rectal Cancer.
    Sun H; Xu Y; Xu Q; Duan J; Zhang H; Liu T; Li L; Chan Q; Xie S; Wang W
    Acad Radiol; 2019 Jul; 26(7):e134-e140. PubMed ID: 30268719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.
    Vidiri A; Gangemi E; Ruberto E; Pasqualoni R; Sciuto R; Sanguineti G; Farneti A; Benevolo M; Rollo F; Sperati F; Spasiano F; Pellini R; Marzi S
    PLoS One; 2020; 15(3):e0229611. PubMed ID: 32119697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Invasive Estimation of Glioma
    Hu Y; Chen Y; Wang J; Kang JJ; Shen DD; Jia ZZ
    Front Oncol; 2020; 10():593102. PubMed ID: 33425744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.
    Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J
    Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain Glioma Localization Diagnosis Based on Magnetic Resonance Imaging.
    Jin Y; Peng H; Peng J
    World Neurosurg; 2021 May; 149():325-332. PubMed ID: 32992057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between histogram metrics of pharmacokinetic parameters of DCE-MRI and histological phenotype in breast cancer.
    Yang G; Yang J; Xu H; Zhang Q; Qi Y; Zhang A
    Transl Cancer Res; 2020 Jan; 9(1):30-41. PubMed ID: 35117155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
    Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
    Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations Between Histogram Analysis DCE MRI Parameters and Complex
    Surov A; Leifels L; Meyer HJ; Winter K; Sabri O; Purz S
    Anticancer Res; 2018 Mar; 38(3):1637-1642. PubMed ID: 29491096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole Lesion Histogram Analysis Derived From Morphological MRI Sequences Might be Able to Predict EGFR- and Her2-Expression in Cervical Cancer.
    Meyer HJ; Hamerla G; Höhn AK; Surov A
    Acad Radiol; 2019 Aug; 26(8):e208-e215. PubMed ID: 30318289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer.
    Romeo V; Cavaliere C; Imbriaco M; Verde F; Petretta M; Franzese M; Stanzione A; Cuocolo R; Aiello M; Basso L; Amitrano M; Lauria R; Accurso A; Brunetti A; Salvatore M
    Eur J Radiol; 2020 May; 126():108907. PubMed ID: 32145597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.
    Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
    Clin Radiol; 2018 May; 73(5):460-466. PubMed ID: 29295753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis.
    Kim SH; Lee HS; Kang BJ; Song BJ; Kim HB; Lee H; Jin MS; Lee A
    PLoS One; 2016; 11(12):e0168632. PubMed ID: 28036342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.
    Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M
    Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.